These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16985365)

  • 1. Visualization of hepatic metastases of medullary thyroid carcinoma on Tc-99m MDP bone scintigraphy.
    Ali I; Johns W; Gupta SM
    Clin Nucl Med; 2006 Oct; 31(10):611-3. PubMed ID: 16985365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatic metastasis from medullary thyroid cancer with Tc-99m-MIBI scintigraphy in a patient with Sipple's syndrome.
    Sato S; Okumura Y; Tamizu A; Maki K; Akaki S; Takeda Y; Kanazawa S; Hiraki Y
    Ann Nucl Med; 2001 Oct; 15(5):443-6. PubMed ID: 11758951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of medullary carcinoma of thyroid, with liver metastasis, using 99mTc DMSA(V) scintigraphy.
    Shikare S; Bashir K; Menon PS; Bapat RD; Tilve GH
    J Postgrad Med; 1995; 41(1):12-3. PubMed ID: 10740693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m MDP scan in medullary carcinoma of the thyroid with bone marrow invasion.
    Turpin S; Villeneuve H
    Clin Nucl Med; 1998 Jun; 23(6):389-90. PubMed ID: 9619333
    [No Abstract]   [Full Text] [Related]  

  • 5. AJR Teaching File: multiple symmetric abnormalities in a radionuclide bone scan.
    Nguyen BD; Ram PC
    AJR Am J Roentgenol; 2007 Sep; 189(3 Suppl):S32-4. PubMed ID: 17715075
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of medullary carcinoma of the thyroid with I-131 MIBG.
    Thomas CC; Cowan RJ; Albertson DA; Cooper MR
    Clin Nucl Med; 1994 Dec; 19(12):1066-8. PubMed ID: 7874804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
    Czepczyński R; Kosowicz J; Ziemnicka K; Mikołajczak R; Gryczyńska M; Sowiński J
    Endokrynol Pol; 2006; 57(4):431-5. PubMed ID: 17006849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual widespread metastatic presentation of mixed medullary-follicular thyroid carcinoma.
    Bhatnagar P; Bhatnagar A; Kishan S; Bal CS; Saran RK; Sinha S; Kashyap R
    Clin Nucl Med; 2004 May; 29(5):303-5. PubMed ID: 15069329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the 99mTc-MDP scan in the detection of calcified liver metastases.
    Tokuue K; Furuse M
    Nuklearmedizin; 1990 Nov; 29(5):231-3. PubMed ID: 2277774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA.
    Yen TC; King KL; Yang AH; Liu RS; Yeh SH
    J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma.
    Learoyd DL; Roach PJ; Briggs GM; Delbridge LW; Wilmshurst EG; Robinson BG
    J Nucl Med; 1997 Feb; 38(2):227-30. PubMed ID: 9025742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of metastatic liver disease on technetium-99m bone scintigraphy.
    Romyn AM; Bushnell DL; Freeman ML; Kaplan E
    Clin Nucl Med; 1987 Apr; 12(4):264-7. PubMed ID: 3581604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201.
    Adalet I; Demirkale P; Unal S; Oůz H; Alagöl F; Cantez S
    Clin Nucl Med; 1999 Sep; 24(9):678-83. PubMed ID: 10478744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
    Szakáll S; Bajzik G; Repa I; Miklovicz T; Dabasi G; Sinkovics I; Esik O
    Orv Hetil; 2002 May; 143(21 Suppl 3):1280-3. PubMed ID: 12077916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents.
    Kiratli PO; Kara PP; Ergün EL; Gedikoğlu G
    Ann Nucl Med; 2004 Jul; 18(5):443-6. PubMed ID: 15462407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of a bone imaging agent in liver metastases from prostate carcinoma.
    Haseman MK
    Clin Nucl Med; 1983 Oct; 8(10):488-9. PubMed ID: 6228362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid.
    Lebouthillier G; Morais J; Picard M; Picard D; Chartrand R; D'Amour P
    Clin Nucl Med; 1993 Aug; 18(8):657-61. PubMed ID: 8403695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.